PBH
Price
$45.26
Change
+$0.49 (+1.09%)
Updated
Oct 2 closing price
Capitalization
2.22B
31 days until earnings call
Intraday BUY SELL Signals
PRGO
Price
$14.26
Change
+$0.24 (+1.71%)
Updated
Oct 2 closing price
Capitalization
2.1B
37 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

PBH vs PRGO

PBH vs PRGO Comparison Chart in %
View a ticker or compare two or three
VS
PBH vs. PRGO commentary
Oct 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PBH is a Hold and PRGO is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
PBH vs PRGO: Fundamental Ratings
PBH
PRGO
OUTLOOK RATING
1..100
6385
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
54
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7498
PRICE GROWTH RATING
1..100
7542
P/E GROWTH RATING
1..100
492
SEASONALITY SCORE
1..100
8575

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

PRGO's Valuation (54) in the Pharmaceuticals Other industry is in the same range as PBH (68). This means that PRGO’s stock grew similarly to PBH’s over the last 12 months.

PRGO's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as PBH (100). This means that PRGO’s stock grew similarly to PBH’s over the last 12 months.

PBH's SMR Rating (74) in the Pharmaceuticals Other industry is in the same range as PRGO (98). This means that PBH’s stock grew similarly to PRGO’s over the last 12 months.

PRGO's Price Growth Rating (42) in the Pharmaceuticals Other industry is somewhat better than the same rating for PBH (75). This means that PRGO’s stock grew somewhat faster than PBH’s over the last 12 months.

PRGO's P/E Growth Rating (2) in the Pharmaceuticals Other industry is somewhat better than the same rating for PBH (49). This means that PRGO’s stock grew somewhat faster than PBH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PBHPRGO
RSI
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
74%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
56%
Bearish Trend 4 days ago
76%
Momentum
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
68%
MACD
ODDS (%)
Bearish Trend 4 days ago
50%
Bearish Trend 4 days ago
70%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
59%
Bearish Trend 4 days ago
68%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
56%
Bearish Trend 4 days ago
64%
Advances
ODDS (%)
Bullish Trend 8 days ago
53%
Bullish Trend 11 days ago
63%
Declines
ODDS (%)
Bearish Trend 5 days ago
57%
Bearish Trend 5 days ago
69%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
66%
Bearish Trend 4 days ago
66%
Aroon
ODDS (%)
Bearish Trend 4 days ago
55%
Bullish Trend 4 days ago
54%
COMPARISON
Comparison
Oct 05, 2026
Stock price -- (PBH: $45.26 vs. PRGO: $14.26)
Brand notoriety: PBH and PRGO are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: PBH: 96% vs. PRGO: 76%
Market capitalization -- PBH: $2.22B vs. PRGO: $2.1B
PBH [@Pharmaceuticals: Generic] is valued at $2.22B. PRGO’s [@Pharmaceuticals: Generic] market capitalization is $2.1B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PBH’s FA Score shows that 0 FA rating(s) are green while PRGO’s FA Score has 1 green FA rating(s).

  • PBH’s FA Score: 0 green, 5 red.
  • PRGO’s FA Score: 1 green, 4 red.
According to our system of comparison, PRGO is a better buy in the long-term than PBH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PBH’s TA Score shows that 5 TA indicator(s) are bullish while PRGO’s TA Score has 4 bullish TA indicator(s).

  • PBH’s TA Score: 5 bullish, 5 bearish.
  • PRGO’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, PBH is a better buy in the short-term than PRGO.

Price Growth

PBH (@Pharmaceuticals: Generic) experienced а -2.90% price change this week, while PRGO (@Pharmaceuticals: Generic) price change was -7.52% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -4.61%. For the same industry, the average monthly price growth was -8.00%, and the average quarterly price growth was +30.03%.

Reported Earning Dates

PBH is expected to report earnings on Nov 05, 2026.

PRGO is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-4.61% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
PBH
Daily Signal:
Gain/Loss:
PRGO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
STXF49.770.36
+0.73%
Strive 500 ETF (STXF)
IETH18.61N/A
N/A
Bitwise Ethereum Option Income Strategy ETF
WRTH25.05N/A
N/A
Worth Charting Options Income ETF (WRTH)
DFEN47.44-0.10
-0.21%
Direxion Daily Aerospace & Defense Bull 3X ETF (DFEN)
ELIL26.99-0.38
-1.37%
Direxion Daily LLY Bull 2X ETF (ELIL)

PBH and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBH has been loosely correlated with HLN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PBH jumps, then HLN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBH
1D Price
Change %
PBH100%
+1.09%
HLN - PBH
37%
Loosely correlated
+0.92%
PRGO - PBH
34%
Loosely correlated
+1.71%
AMPH - PBH
32%
Poorly correlated
+0.32%
ANIP - PBH
31%
Poorly correlated
-1.07%
ELAN - PBH
29%
Poorly correlated
+1.70%
More

PRGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRGO has been loosely correlated with SUPN. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRGO jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRGO
1D Price
Change %
PRGO100%
+1.71%
SUPN - PRGO
49%
Loosely correlated
+0.47%
ELAN - PRGO
37%
Loosely correlated
+1.70%
EVO - PRGO
35%
Loosely correlated
-2.74%
PBH - PRGO
35%
Loosely correlated
+1.09%
ALVO - PRGO
34%
Loosely correlated
-3.02%
More